Research & Reports

Novartis has published its 2015 Corporate Responsibility (CR) Performance Report. The report is based on the Global Reporting Initiative G4 guidelines, with disclosure at “comprehensive” level, making it the first comprehensive level-report in the healthcare industry.

From all corners of the world, business leaders echo the same message: societal risks need urgent action. However, some of the most pressing risks – such as youth unemployment and the global food crisis – are also where leaders see the greatest business opportunities.

A new report, launched today by CDP and BSR, highlights the largest ever study of climate data from suppliers and their corporate customers.

With today’s modern technology, we now have the ability to manage all aspects of our grant-giving, including the ability to measure effectiveness, right at our fingertips.

Time, energy, and effectiveness. These are three vital resources for nonprofit organizations. The challenge of reporting compliance consumes all three and distracts them from their purpose. Is there a way to keep them from drowning in that sea of paperwork?

Many corporations are looking to utilize online solutions, unaware of the hidden cost of implementation when selecting a grants management system.

Depending on the size of your company and the industry you’re in, it can sometimes be difficult to determine what corporate giving route would be the most successful. Although there are countless corporate giving programs out there, there are four types that stand out.

Data is how you measure your impact, but access and interpretation are the only way you can make those measurements. The options to put this data to work are growing. What do you need? Here’s the corporate grantmaker’s guide to data.

Join GRI and up to 1,500 sustainability leaders for frank and forward thinking discussions on the latest trends and innovations shaping sustainability: policy, standards and technology to name a few. 5 DAYS LEFT TO SECURE YOUR REDUCED RATE - REGISTER NOW!

Novartis 2015 CR highlights: Launched Novartis Access, a portfolio of 15 medicines to treat the main noncommunicable diseases in lower-income countries at a cost of USD 1 per treatment per month; Provided medicine to 66 million patients through access programs; Reached 7.6 million people through social business initiatives in India, Kenya, Vietnam and Indonesia.


•Launched a new Group-wide program to ensure our ethical standards are firmly embedded in our business practices